Perceptive Capital Solutions Corp (PCSC) Financial Statements
Industry: Medical Laboratories (Services)
In fiscal 2025, Perceptive Capital Solutions reported revenue of $0. Net income was $837,468, or $0.08 per diluted share. Operating activities generated -$864,653 of cash. At fiscal year end, Perceptive Capital Solutions held $92.8M in total assets against $5.7M in total liabilities.
Open the full interactive Perceptive Capital Solutions financials → Quarterly statements, key ratios, valuation history and price charts.
Perceptive Capital Solutions Key Stats
| Share Price | $12.64 |
|---|---|
| Market Cap | $106.9M |
| P/E Ratio | 158.0 |
| 52-Week Range | $9.99 – $17.11 |
| Shares Outstanding | 8.5 million (basic, 2026 Q2) |
Perceptive Capital Solutions Income Statement
| FY 2024 | FY 2025 | |
|---|---|---|
| Revenue | $0 | $0 |
| Cost of Goods Sold | $0 | — |
| Gross Profit | $0 | — |
| Operating Income | — | -$3.0M |
| Pre-Tax Income | $0 | $837,468 |
| Net Income | $0 | $837,468 |
| Diluted EPS | — | $0.08 |
Perceptive Capital Solutions Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net Income | $144,634 | -$740,568 | -$51,749 | -$114,943 |
| Diluted EPS | $0.01 | -$0.09 | -$0.01 | -$0.01 |
Perceptive Capital Solutions Balance Sheet
| FY 2024 | FY 2025 | |
|---|---|---|
| Current Assets | $1.2M | $907,570 |
| Total Assets | $89.9M | $92.8M |
| Current Liabilities | $210,811 | $2.3M |
| Total Liabilities | $3.7M | $5.7M |
| Shareholders' Equity | -$2.1M | -$4.8M |
Perceptive Capital Solutions Cash Flow Statement
| FY 2024 | FY 2025 | |
|---|---|---|
| Cash From Operations | -$353,623 | -$864,653 |
| Cash From Investing | -$86.2M | $600,000 |
| Cash From Financing | $87.7M | $0 |
Figures from Perceptive Capital Solutions' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Perceptive Capital Solutions financials page for every line item.
Perceptive Capital Solutions Company Profile
| Ticker | PCSC |
|---|---|
| Exchange | Nasdaq |
| Industry | Medical Laboratories (Services) |
| Headquarters | Brisbane, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company, emerging growth company |
| SEC CIK | 0002017526 |
Frequently Asked Questions
What was Perceptive Capital Solutions' revenue in fiscal 2025?
Perceptive Capital Solutions (PCSC) reported revenue of $0 for fiscal 2025.
What was Perceptive Capital Solutions' net income in fiscal 2025?
Perceptive Capital Solutions reported net income of $837,468 for fiscal 2025.
What was Perceptive Capital Solutions' earnings per share (EPS) in fiscal 2025?
Perceptive Capital Solutions' diluted EPS was $0.08 for fiscal 2025 (adjusted for any later stock splits).
What was Perceptive Capital Solutions' revenue last quarter?
In its most recent reported quarter (2026 Q2), Perceptive Capital Solutions reported revenue of $0.
How many shares of Perceptive Capital Solutions are outstanding?
Perceptive Capital Solutions reported a weighted average of 8.5 million basic shares outstanding in 2026 Q2.
What is Perceptive Capital Solutions' market cap?
Based on its latest closing price, Perceptive Capital Solutions (PCSC) has a market capitalization of about $106.9M.
When does Perceptive Capital Solutions' fiscal year end?
Perceptive Capital Solutions' fiscal year end, as registered with the SEC, is December 31.
Where is Perceptive Capital Solutions headquartered?
Perceptive Capital Solutions lists its business address in Brisbane, California in its SEC filings.